The age at ovarian cancer diagnosis is older for women with mutations in RAD51D, suggesting that it is safe to delay risk-reducing salpingo-oophorectomy (RRSO) until age 45–50 in RAD51D mutation carriers [38]. Here, RAD51D is linked to ovarian carcinoma.